5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.53▲ | 2.50▲ | 2.48▲ | 2.47▲ | 2.36▲ |
MA10 | 2.45▲ | 2.41▲ | 2.39▲ | 2.39▲ | 2.43▲ |
MA20 | 2.35▲ | 2.33▲ | 2.32▲ | 2.30▲ | 2.53▲ |
MA50 | 2.33▲ | 2.36▲ | 2.37▲ | 2.46▲ | 2.62▲ |
MA100 | 2.54▲ | 2.54▲ | 2.53▲ | 2.52▲ | 2.80▼ |
MA200 | 2.61▼ | 2.59▲ | 2.59▲ | 2.56▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.036▲ | 0.041▲ | 0.044▲ | 0.049▲ | 0.005▲ |
RSI | 67.825▲ | 65.912▲ | 65.463▲ | 62.924▲ | 52.779▲ |
STOCH | 100.000▲ | 93.056▲ | 93.056▲ | 80.982▲ | 24.769 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -8.772▲ | -46.078 |
CCI | 135.992▲ | 148.368▲ | 162.216▲ | 232.823▲ | 10.941 |
Tuesday, September 30, 2025 12:32 PM
By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA) said a study led by The University of Kansas Cancer Center, is testing Lisata’s investigational peptide certepetide with FOLFIRINOX-based therapies ...
|
Monday, September 29, 2025 05:14 AM
Results to be presented at the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions BASKING RIDGE, N.J., Sept. 29, 2025 ...
|
Wednesday, August 20, 2025 05:58 AM
HOUSTON — Six more Houston-based companies have joined the New York Stock Exchange’s new Dallas-based electronic equities exchange in the past few days. All joined the NYSE Texas as founding members ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 2.55 | 2.67 | 2.50 | 2.62 | 30,202 |
29/09/25 | 2.32 | 2.61 | 2.32 | 2.53 | 47,108 |
26/09/25 | 2.25 | 2.47 | 2.2454 | 2.47 | 21,742 |
25/09/25 | 2.30 | 2.42 | 2.182 | 2.365 | 53,756 |
24/09/25 | 2.29 | 2.3853 | 2.20 | 2.35 | 14,616 |
23/09/25 | 2.28 | 2.3338 | 2.23 | 2.29 | 4,938 |
22/09/25 | 2.26 | 2.3973 | 2.14 | 2.29 | 41,998 |
19/09/25 | 2.38 | 2.40 | 2.24 | 2.33 | 18,325 |
18/09/25 | 2.28 | 2.39 | 2.28 | 2.39 | 7,046 |
17/09/25 | 2.29 | 2.432 | 2.19 | 2.28 | 11,759 |
|
|
||||
|
|
||||
|
|